Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina Dib

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Scandinavian Journal of Gastroenterology|June 20, 2022
How are patients' preferences for anti-TNF influenced by quality of life? A discrete choice experiment in Crohn's disease patientsSolène Brunet-Houdard, Fanny Monmousseau, Geoffrey Berthon, et al.
Scandinavian Journal of Gastroenterology|February 21, 2022
Predictors of each quality of life dimension in Crohn's disease patients initiating an anti-TNF treatment: differentiated effects of patient-, disease-, and treatment-related characteristicsFanny Monmousseau, Lucile Mulot, Emmanuel Rusch, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2010
Diagnosis of different liver fibrosis characteristics by blood tests in non-alcoholic fatty liver diseasePaul Calès, Jérôme Boursier, Julien Chaigneau, et al.
Journal of Crohn'S & Colitis|May 18, 2020
VALIDation of the IBD-Disk Instrument for Assessing Disability in Inflammatory Bowel Diseases in a French Cohort: The VALIDate StudyCatherine Le Berre, Mathurin Flamant, Guillaume Bouguen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 4, 2009
The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosisJérôme Boursier, Julien Vergniol, Apollinaire Sawadogo, et al.
European Journal of Gastroenterology & Hepatology|September 10, 2011
Steatosis degree, measured by morphometry, is linked to other liver lesions and metabolic syndrome components in patients with NAFLDJérôme Boursier, Julien Chaigneau, Vincent Roullier, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 17, 2019
Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitisLoriane Lair-Mehiri, Carmen Stefanescu, Thibaut Vaysse, et al.
Journal of Gastroenterology|May 18, 2013
Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis CJérôme Boursier, Victor de Ledinghen, Nathalie Sturm, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2020
Vedolizumab for perianal Crohn's disease: a multicentre cohort study in 151 patientsConstance Chapuis-Biron, Anne Bourrier, Maria Nachury, et al.
Journal of Crohn'S & Colitis|January 14, 2020
Maintenance of Remission Among Patients With Inflammatory Bowel Disease After Vedolizumab Discontinuation: A Multicentre Cohort StudyAntoine Martin, Maria Nachury, Laurent Peyrin-Biroulet, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Scandinavian Journal of Gastroenterology|June 20, 2022
How are patients' preferences for anti-TNF influenced by quality of life? A discrete choice experiment in Crohn's disease patientsSolène Brunet-Houdard, Fanny Monmousseau, Geoffrey Berthon, et al.
Scandinavian Journal of Gastroenterology|February 21, 2022
Predictors of each quality of life dimension in Crohn's disease patients initiating an anti-TNF treatment: differentiated effects of patient-, disease-, and treatment-related characteristicsFanny Monmousseau, Lucile Mulot, Emmanuel Rusch, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2010
Diagnosis of different liver fibrosis characteristics by blood tests in non-alcoholic fatty liver diseasePaul Calès, Jérôme Boursier, Julien Chaigneau, et al.
Journal of Crohn'S & Colitis|May 18, 2020
VALIDation of the IBD-Disk Instrument for Assessing Disability in Inflammatory Bowel Diseases in a French Cohort: The VALIDate StudyCatherine Le Berre, Mathurin Flamant, Guillaume Bouguen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 4, 2009
The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosisJérôme Boursier, Julien Vergniol, Apollinaire Sawadogo, et al.
European Journal of Gastroenterology & Hepatology|September 10, 2011
Steatosis degree, measured by morphometry, is linked to other liver lesions and metabolic syndrome components in patients with NAFLDJérôme Boursier, Julien Chaigneau, Vincent Roullier, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 17, 2019
Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitisLoriane Lair-Mehiri, Carmen Stefanescu, Thibaut Vaysse, et al.
Journal of Gastroenterology|May 18, 2013
Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis CJérôme Boursier, Victor de Ledinghen, Nathalie Sturm, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2020
Vedolizumab for perianal Crohn's disease: a multicentre cohort study in 151 patientsConstance Chapuis-Biron, Anne Bourrier, Maria Nachury, et al.
Journal of Crohn'S & Colitis|January 14, 2020
Maintenance of Remission Among Patients With Inflammatory Bowel Disease After Vedolizumab Discontinuation: A Multicentre Cohort StudyAntoine Martin, Maria Nachury, Laurent Peyrin-Biroulet, et al.
Pageof 4